Tempest Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.

About TPST

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. 

CEO
Matthew Angel
CEOMatthew Angel
Employees
4
Employees4
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2011
Founded2011
Employees
4
Employees4

TPST Key Statistics

Market cap
7.70M
Market cap7.70M
Price-Earnings ratio
-0.09
Price-Earnings ratio-0.09
Dividend yield
—
Dividend yield—
Average volume
311.28K
Average volume311.28K
High today
$0.41
High today$0.41
Low today
$0.3602
Low today$0.3602
Open price
$0.383
Open price$0.383
Volume
153.30K
Volume153.30K
52 Week high
$9.75
52 Week high$9.75
52 Week low
$0.3367
52 Week low$0.3367

Stock Snapshot

The current Tempest Therapeutics(TPST) stock price is $0.37, with a market capitalization of 7.7M. The stock trades at a price-to-earnings (P/E) ratio of -0.09.

On 2026-11-15, Tempest Therapeutics(TPST) stock traded between a low of $0.36 and a high of $0.41. Shares are currently priced at $0.37, which is +3.5% above the low and -9.1% below the high.

Tempest Therapeutics(TPST) shares are trading with a volume of 153.3K, against a daily average of 311.28K.

During the past year, Tempest Therapeutics(TPST) stock moved between $0.34 at its lowest and $9.75 at its peak.

During the past year, Tempest Therapeutics(TPST) stock moved between $0.34 at its lowest and $9.75 at its peak.

TPST News

TipRanks 10h
Leadership Turmoil at Tempest Therapeutics Raises Governance and Investor Confidence Risks

Tempest Therapeutics, Inc. (TPST) has disclosed a new risk, in the Corporate Activity and Growth category. Tempest Therapeutics, Inc. has experienced substanti...

TipRanks 3d
Tempest Therapeutics Exercises Rights to CD7 CAR-T Platform

The latest announcement is out from Tempest Therapeutics ( (TPST) ). On November 11, 2026, Tempest Therapeutics exercised its option under a September 14, 2026...

People also own

Based on the portfolios of people who own TPST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.